Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.
Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.
复制标题
DOI:
10.1021/jm101087u
复制
发表时间:
2010-12-09
影响因子:
7.3
通讯作者:
Long YQ
中科院分区:
文献类型:
--
作者:
Huang SX;Li HY;Liu JY;Morisseau C;Hammock BD;Long YQ
The inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of hypertension, inflammation and other disorders. However, the problems of limited water solubility, high melting point and low metabolic stability complicated the development of 1,3-disubstituted urea-based sEH inhibitors. The current study explored the introduction of the substituted piperazino group as the tertiary pharmacophore, which resulted in substantial improvements in pharmacokinetic parameters over previously reported 1-adamantyl-urea based inhibitors while retaining high potency. The SAR studies revealed that the meta- or para-substituted phenyl spacer, and N4-acetyl or sulfonyl substituted piperazine were optimal structures for achieving high potency and good physical properties. The 1-(4-(4-(4-acetylpiperazin-1-yl)butoxy)phenyl)-3-adamantan-1-yl urea (29c) demonstrated excellent in vivo pharmacokinetic properties in mice: T1/2 =14 h, Cmax = 84 nM and AUC = 40200 nM • min with an IC50 value of 7.0 nM against human sEH enzyme.
登录
查看更多内容
影响因子:
2.7
作者:
Anandan, Sampath-Kumar;Webb, Heather K.;Gless, Richard D.
通讯作者:
Gless, Richard D.
影响因子:
8.3
作者:
Imig, JD;Zhao, XY;Hammock, BD
通讯作者:
Hammock, BD
影响因子:
7.3
作者:
Hwang, Sung Hee;Tsai, Hsing-Ju;Hammock, Bruce D.
通讯作者:
Hammock, Bruce D.
影响因子:
2.7
作者:
Eldrup, Anne B.;Soleymanzadeh, Fariba;De Lombaert, Stephane
通讯作者:
De Lombaert, Stephane
影响因子:
7.3
作者:
Kim, IH;Morisseau, C;Hammock, BD
通讯作者:
Hammock, BD